SM
Stephen Morlock
Director

Stephen Morlock insider trades: BioPharmX (BPMX) stock buys and sales

Director, BioPharmX Last trade Oct 22, 2018 18 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2015
1
Company
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Stephen reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 22, 2018BPMX↓ Sell$162K
Oct 22, 2018BPMX↓ Sell$45K
Nov 24, 2017BPMX↑ Buy$50K
Jan 14, 2016BPMX↑ Buy$18K
Jan 12, 2016BPMX↑ Buy$9K
Jan 7, 2016BPMX↑ Buy$7K
Oct 15, 2015BPMX↑ Buy$6K
Oct 9, 2015BPMX↑ Buy$4K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Stephen Morlock's insider trades

Stephen Morlock is a director at BioPharmX (BPMX). Since Oct 9, 2015, Stephen has reported 6 open-market purchases worth $94K and 2 sales worth $207K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (10 filings), other transactions (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BPMX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.